Yan Lan

Person

Belmont, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Interleukin-12 targeted to oncofoetal fibronectin
- Patent number 8,420,087
- Issue date Apr 16, 2013
- Antisoma Research Limited
- Stephen Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Patent number 7,879,319
- Issue date Feb 1, 2011
- Merk Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Patent number 7,576,193
- Issue date Aug 18, 2009
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhancement of antibody-cytokine fusion protein mediated immune res...
- Patent number 7,517,526
- Issue date Apr 14, 2009
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Patent number 7,226,998
- Issue date Jun 5, 2007
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Patent number 6,838,260
- Issue date Jan 4, 2005
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Combination Therapy for Cancer
- Publication number 20220017621
- Publication date Jan 20, 2022
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED INHIBITION OF PD-1/PD-L1, TGFB AND DNA-PK FOR THE TREATMEN...
- Publication number 20210246208
- Publication date Aug 12, 2021
- Merck Patent GmbH
- Yan LAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF STAGE III NSCLC AND MITIGATION OF PATHOLOGICAL CONDITI...
- Publication number 20210113656
- Publication date Apr 22, 2021
- Merck Patent GmbH
- Italia Grenga
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR CANCER
- Publication number 20180118832
- Publication date May 3, 2018
- Merck Patent GmbH
- Kin-Ming Lo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES
- Publication number 20130017168
- Publication date Jan 17, 2013
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RES...
- Publication number 20100297060
- Publication date Nov 25, 2010
- Merck Patent GmbH
- STEPHEN D. GILLIES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC FUSION PROTEINS USEFUL FOR TARGETED IMMUNE THERAPY AN...
- Publication number 20100015089
- Publication date Jan 21, 2010
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCING THE CIRCULATING HALF-LIFE OF ANTIBODY-BASED FUSION PROTEINS
- Publication number 20090088561
- Publication date Apr 2, 2009
- Merck Patent GmbH
- Stephen Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Publication number 20080311655
- Publication date Dec 18, 2008
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for enhancing the efficacy of IL-2 mediated immune responses
- Publication number 20080025947
- Publication date Jan 31, 2008
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds For Targeting
- Publication number 20070202103
- Publication date Aug 30, 2007
- EMD Lexigen Research Center Corp.
- Stephen Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Enhancing the circulating half-life of antibody-based fusion proteins
- Publication number 20060194952
- Publication date Aug 31, 2006
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Publication number 20050137384
- Publication date Jun 23, 2005
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCING THE CIRCULATING HALF LIFE OF ANTIBODY-BASED FUSION PROTEINS
- Publication number 20030105294
- Publication date Jun 5, 2003
- STEPHEN GILLIES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Enhancement of antibody-cytokine fusion protein mediated immune res...
- Publication number 20030049227
- Publication date Mar 13, 2003
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterodimeric fusion proteins useful for targeted immune therapy an...
- Publication number 20020193570
- Publication date Dec 19, 2002
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Interleukin-12 targeted to oncofoetal fibronectin

Heterodimeric fusion proteins useful for targeted immune therapy an...

Heterodimeric fusion proteins useful for targeted immune therapy an...

Enhancement of antibody-cytokine fusion protein mediated immune res...

Heterodimeric fusion proteins useful for targeted immune therapy an...

Heterodimeric fusion proteins useful for targeted immune therapy an...

Patents Applicationslast 30 patents

Combination Therapy for Cancer

COMBINED INHIBITION OF PD-1/PD-L1, TGFB AND DNA-PK FOR THE TREATMEN...

TREATMENT OF STAGE III NSCLC AND MITIGATION OF PATHOLOGICAL CONDITI...

COMBINATION THERAPY FOR CANCER

METHODS FOR ENHANCING THE EFFICACY OF IL-2 MEDIATED IMMUNE RESPONSES

ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RES...

HETERODIMERIC FUSION PROTEINS USEFUL FOR TARGETED IMMUNE THERAPY AN...

ENHANCING THE CIRCULATING HALF-LIFE OF ANTIBODY-BASED FUSION PROTEINS

Heterodimeric fusion proteins useful for targeted immune therapy an...

Methods for enhancing the efficacy of IL-2 mediated immune responses

Compounds For Targeting

Enhancing the circulating half-life of antibody-based fusion proteins

Heterodimeric fusion proteins useful for targeted immune therapy an...

ENHANCING THE CIRCULATING HALF LIFE OF ANTIBODY-BASED FUSION PROTEINS

Enhancement of antibody-cytokine fusion protein mediated immune res...

Heterodimeric fusion proteins useful for targeted immune therapy an...